President Donald Trump will direct his top health officials to conduct a systematic review of the childhood vaccinations ...

Previously, Galmed announced the grant of new use patent for a combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH. The new patent extends Aramchol's patent ...

The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving ...

Underscoring India's rising influence in global cardiovascular innovation, Meril Life Sciences presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the ...

Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing and ...

The inducement equity awards were granted effective as of December 1, 2025, and consist of non-statutory stock options to purchase up to an aggregate of 51,600 shares of Ocular’s common stock and ...

This peer-reviewed publication marks an important milestone following initial release of study information in August 2024 (see "Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT"). The ...

Advisors to the Centers for Disease Control and Prevention (CDC) voted 8-3 Friday to recommend that a mother without ...

Q3 2026 Earnings Call Transcript December 2, 2025 Asana, Inc. misses on earnings expectations. Reported EPS is $-0.28779 EPS, ...

Asana, Inc. ( ASAN) Q3 2026 Earnings Call December 2, 2025 4:30 PM EST Thank you for standing by, and welcome to Asana's Third Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions ...

Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced the appointment of Luke Gill, ...

The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...